4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0000899243-15-006854
$ORKACIK 0000907654operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:15 PM ET
Size
5.9 KB
Accession
0000899243-15-006854
Insider Transaction Report
Form 4
Keuer Thomas A
Chief Operating Officer
Transactions
- Sale
Common Stock
2015-10-16$5.14/sh−496$2,549→ 16,938 total
Footnotes (2)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person for satisfaction of their tax withholding obligation with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
- [F2]Includes (i) remaining 2,143 previously reported shares issued as RSUs under the Plan that vests on 9/17/16, (ii) remaining 1,429 previously reported shares issued as RSUs under the Plan that vests on 10/15/16, (iii) 3,664 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning on 2/27/16, and (iv) 3,621 previously reported shares issued as RSUs under the Plan that vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 6,081 previously reported shares of common stock owned.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:15 PM ET
- Size
- 5.9 KB